Recent Articles from Investor Brand Network

AZIO AI Holdings (NASDAQ: AZIO) has unveiled Atlas One, a South Texas data center campus designed to address growing AI computing demand by developing dedicated, on-site power infrastructure. Spanning more than 548 acres, the project is engineered for up to 500 megawatts of planned behind-the-meter power capacity, with approximately 11 megawatts of natural gas generation and supporting electrical infrastructure already secured and about 6 megawatts activated for an initial Bitcoin mining workload. The company has also committed approximately $2.4 million to an AT&T agreement for dedicated enterprise fiber connectivity. Atlas One is intended to connect Azio AI’s GPU hardware business with its planned hosting infrastructure, complementing a separate agreement to sell up to 512 NVIDIA HGX B300 GPU systems to Power Champion Investment Limited for an estimated $307 million.

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

VERAXA Biotech (NASDAQ: VRXA) is developing antibody-based cancer therapies designed to improve treatment selectivity and potentially reduce toxicity to healthy tissues. At the center of its strategy is the proprietary BiTAC (Bi-targeted Tumor-Associated Cytotoxicity) platform, which uses two complementary molecules designed to activate cancer-killing activity only when both recognize targets on the same tumor cell. The company is applying this approach to antibody-drug conjugates (“ADCs”) and T-cell engagers (“TCEs”), with a particular focus on solid tumors. VERAXA reported promising preclinical findings for its lead BiTAC-TCE program, including selective targeting of cells expressing both intended targets and improved safety alongside comparable efficacy to a conventional TCE in animal studies. The company is also developing complementary ADC technologies, including site-specific conjugation and tumor-selective payload-linker systems, in markets experiencing substantial projected growth.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

Disseminated on behalf of SuperQ Quantum Computing Inc. and may include paid advertisements.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

As defense organizations and commercial operators expand their use of unmanned systems, the technologies that keep these platforms connected, secure and operational are becoming increasingly important. Mobilicom (NASDAQ: MOB) addresses these needs through an integrated portfolio of cybersecurity, software and hardware designed for drones, robotics and other autonomous platforms operating in demanding environments.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

Anthropic, one of the leading companies building advanced artificial intelligence, has reportedly shared a draft law with members of the United States Congress. The proposal focuses on how the government should respond when powerful AI systems may become dangerous. It does not try to regulate every AI product. Instead, it aims at the most advanced models, often called frontier AI, which could one day cause serious harm if they fail or are misused.

Anthropic’s most advanced AI model has cracked a set of problems in quantum computing that took human researchers years to make progress on, completing the work in just over two days. The results, produced without any human involvement during the process, are being seen as a sign that AI is moving beyond answering questions and into territory where it can independently advance scientific research.

Many analysts have been voicing their concerns that the AI boom could face a major correction and bring down other markets, such as commodity markets. However, investors say copper is in a structurally bullish market and the metal can survive if the AI boom unwinds. They point to several factors as the reason for their optimism.

Olenox Industries (NASDAQ: OLOX) an integrated energy and infrastructure company, announced that its CS Digital Ventures operations produced approximately 15.03 Bitcoin in September 2026, with an average operational hashrate of 1.04 exahashes per second and 68% uptime. Mining activity was affected by seasonal power curtailments and reduced equipment speeds to protect miners from summer heat, with normal operating speeds expected to resume in November, subject to conditions. The update follows Olenox’s completion of the Wildboy and Odin acquisitions, which expand its energy platform and support its longer-term strategy of converting company-controlled natural gas into computing power at or near the point of generation. The company aims to reduce energy costs, monetize available gas resources and expand into additional computing applications. September’s preliminary, unaudited results reflect third-party hosted mining operations rather than the company’s planned gas-powered infrastructure.

SKYX Platforms (NASDAQ: SKYX), a platform technology company specializing in smart home and lighting solutions, announced plans to supply more than 80,000 units of its advanced plug-and-play and smart home technologies to over 1,000 residences built by Maronda Homes. The installations are expected to span several states, including Ohio, Georgia, Maryland and Pennsylvania. Founded in 1972, Maronda Homes has built more than 70,000 homes across the United States and currently develops residential communities in 11 states. The agreement expands SKYX’s market penetration as the company advances its strategy of making smart and safe technologies standard features in homes and buildings.

This article has been disseminated on behalf of Trilogy Metals Inc. and may include paid advertising.

TruGolf (NASDAQ: TRUG) announced its placement in an AINewsWire editorial examining the growing adoption of blockchain technology and the expansion of regulated tokenization from traditional financial securities into real-world assets. The editorial, titled “How Regulated Tokenization Is Moving from Wall Street to Main Street Assets,” highlights TruGolf’s acquisition of Polymath Research Inc. and its Polymesh Layer-1 blockchain, establishing a presence in the regulated digital securities infrastructure market. Following the acquisition, TruGolf Links Franchising signed an intercompany agreement with Polymath to provide professional services and migrate its capitalization table onto Polymath’s regulated digital securities infrastructure. The editorial also notes that Polymath is exploring a tokenized film investment platform with CineCity Studios, potentially extending TruGolf’s reach into entertainment finance while maintaining its existing golf business.

ECGI Holdings (OTC: ECGI) is featured in an AINewsWire editorial examining the shift toward preventive, coordinated healthcare and the growing role of artificial intelligence (“AI”) in improving patient outcomes and managing costs. The editorial highlights ECGI’s completed acquisition of Avanta Group, an emerging platform combining a developing Medicare Advantage health plan, management services and AI-driven healthcare technology. The acquisition positions ECGI to pursue opportunities in a U.S. healthcare market that reached $5.3 trillion in spending in 2024, with Medicare Advantage payments projected to reach $574 billion in 2026. The editorial also discusses the potential for Avanta’s integrated platform to improve care coordination, identify gaps in treatment and streamline administrative processes, while noting that regulatory approvals and licenses are still required before its health plan can begin operating.

Silynxcom (NYSE American: SYNX), a developer of advanced soldier-worn tactical communication solutions, announced its strategic entry into the counter-uncrewed aircraft systems (“C-UAS”) market with the development of an artificial intelligence (“AI”)-powered wearable drone detection and early-warning platform. Currently at the prototype stage, the standalone device is designed to identify drone acoustic signatures in real time, including threats from fiber-optic guided drones that conventional radio frequency-based systems may miss. The company is also developing mesh networking capabilities that would allow connected devices to share threat alerts across military units without relying on existing communications infrastructure. Silynxcom is establishing a dedicated counter-drone development team that includes professionals with experience at Israeli drone manufacturers. CEO Nir Klein said the initiative addresses the growing need for individual soldier protection while creating a potential new business line alongside the company’s existing tactical communications products.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

When Stocktwits gathered traders, executives, and financial creators at City Winery in New York City on October 7 for the programming day of Stocktoberfest presented by Tradr ETFs, the agenda was built around two forces the company sees defining how traders find an edge next: agentic trading and social relative strength. Across more than a dozen panels and fireside chats, those two ideas surfaced again and again, alongside sessions on the changing brokerage model, new trading products, and the growing pull of private markets.

JPMorgan Chase (NYSE: JPM) has technically deployed its JPM Coin deposit token on the Ethereum mainnet, enabling eligible institutional clients to transfer funds within seconds, around the clock. According to an Oct. 19 report by Ezra Reguerra and Yohan Yun of Cointelegraph, the token represents U.S. dollar deposits held at JPMorgan. Emma Landriault, global head of Kinexys Labs, said crypto companies could use the token for blockchain payments, while financial institutions could use it to settle trades and post collateral. Landriault said Ethereum was selected for its liquidity and existing use among clients, while JPM Coin transactions will remain restricted to approved institutional participants.

HeartBeam (NASDAQ: BEAT), a medical technology company developing advanced cardiac monitoring solutions, announced the completion of enrollment ahead of schedule in its HEADSTART-ACS study at the National Cardiovascular Center Harapan Kita in Jakarta, Indonesia. The study enrolled 486 patients to evaluate the diagnostic accuracy of the HeartBeam System in detecting acute coronary syndrome (“ACS”), including heart attacks, by comparing its three-dimensional electrocardiogram (“ECG”) technology with standard 12-lead ECGs. Data analysis is underway, with results expected to be presented at a cardiology conference in 2027. Combined with the 132-patient ALIGN-ACS pilot study, HeartBeam has enrolled more than 600 patients across its heart attack detection studies, supporting preparations for a pivotal U.S. study planned for the first quarter of 2027. The company is also exploring potential deployment of its portable, credit card-sized technology across community health centers in Indonesia. The HeartBeam System is not currently cleared for heart attack detection, and its use in both studies remains investigational.

AINewsWire Editorial Coverage : In today’s healthcare landscape, treating sickness after the fact is giving way to stopping it before it starts. U.S. health spending hit $5.3 trillion in 2024, and Medicare Advantage enrolls 35.2 million people today, equal to 55% of those eligible. For 2026, KFF estimates Medicare Advantage payments will hit $574 billion, giving health plans strong financial incentive to keep their members well. A new category of company is emerging to meet that shift. ECGI Holdings Inc. (OTC: ECGI) ( profile ) has finalized its purchase of Avanta Group, an emerging platform combining a Medicare Advantage health plan with management services and AI-driven health technology. Through the acquisition, ECGI gains direct entry into coordinated, proactive care right as the broader industry looks for better ways to deliver it. ECGI now operates in the same space as established names in U.S. managed healthcare, including sector leaders Centene Corporation (NYSE: CNC), Molina Healthcare Inc. (NYSE: MOH), Astrana Health Inc. (NASDAQ: ASTH) and Alignment Healthcare Inc. (NASDAQ: ALHC).

SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, is expanding its international footprint with the launch of Sri Lanka’s first robotic cardiac surgery program at Kings Hospital Colombo, powered by its SSi Mantra 3.0 surgical robotic system. The program began with a robotic-assisted left internal mammary artery takedown performed by company founder and Chairman Dr. Sudhir Srivastava alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva, and the hospital reportedly completed more than 25 robotic procedures within the first three weeks. The launch adds to SS Innovations’ international expansion as the company reported 224 cumulative SSi Mantra installations across 12 countries at the end of the second quarter of 2026. Quarterly revenue increased 39% year over year to $13.9 million, while robotic procedures rose 143% to 2,528, highlighting increased utilization of its installed systems and potential opportunities for recurring revenue from surgical instruments and consumables. SS Innovations is also pursuing broader market access, with U.S. FDA clearance targeted for the first quarter of 2027 and European CE marking targeted for the end of 2026.

Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel technology, designed to promote the regeneration of durable, natural-like cartilage in patients with painful knee cartilage injuries. The cell-free, off-the-shelf implant temporarily fills cartilage defects before gradually resorbing as surrounding tissue regenerates. Long-term MRI findings and peer-reviewed Phase II clinical data have provided evidence of cartilage maturation and durable structural repair, while the company has reported greater pain improvement than traditional microfracture. Regentis has treated 43 of 80 planned patients in its U.S. pivotal Phase III trial, with enrollment expected to conclude around the end of 2026, and is preparing for potential European commercialization under its existing CE Mark approval. The company is also scaling manufacturing following European regulatory approval of a new solvent-free process that it says increases production yield by 400%.

TruGolf Holdings (NASDAQ: TRUG), a producer of advanced golf simulation systems for home or entertainment venues, has completed its acquisition of Polymath Research Inc., bringing a blockchain platform designed for regulated financial assets into the publicly traded golf technology company’s business.

Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, announced the completion of a 1-for-150 reverse stock split effective Oct. 20, 2026, reducing its outstanding common shares from approximately 543.9 million to 3.6 million. The company’s shares began trading on a split-adjusted basis under the temporary symbol NGTFD on Oct. 20 and will revert to NGTF after 20 trading days. The reverse split applies proportionately to all shareholders, with fractional shares rounded up to the next whole share, and does not change the number of authorized shares.

Beeline Holdings (NASDAQ: BLNE), a digital mortgage and home equity platform, announced an additional operating expense reduction plan targeting approximately $250,000 in monthly savings, or $3 million annually, beyond cost reductions implemented earlier in 2026. The initiative includes workforce reductions, infrastructure consolidation and elimination of legacy overhead costs, with approximately $270,000 in one-time transition expenses expected through Dec. 1, 2026. The company anticipates realizing the full monthly savings thereafter, supporting its efforts to improve operating leverage and accelerate its path toward positive operating cash flow. Beeline continues to leverage its MagicBlocks AI customer acquisition technology and new mortgage pricing engine to improve efficiency and support higher-value mortgage products, including Bank Statement and Debt Service Coverage Ratio loans. The company is also advancing its proposed acquisition of TYTL Holdings, Inc. and its broader home equity and blockchain strategy, subject to applicable approvals and closing conditions.

Scinai Immunotherapeutics (NASDAQ: SCNI) issued a shareholder letter from CEO Amir Reichman outlining progress in its contract development and manufacturing organization (“CDMO”) business, strengthened liquidity and an extended operating runway. The company reported approximately $8.1 million in committed customer orders as of Oct. 20, 2026, up more than 300% from $1.9 million at year-end 2025, supported by a new agreement with a U.S.-based biopharmaceutical company that includes approximately $5.1 million in committed base service fees. The agreement also contemplates approximately $5.85 million in additional, uncommitted services, bringing the combined potential opportunity to more than $10 million, subject to further agreements and project milestones.

Elon Musk announced project Terafab, a project that will see him build a manufacturing plant that will produce AI chips on a massive scale. Terafab is currently backed by Tesla, xAI, and SpaceX. All are companies owned by the tech billionaire. So, why would Musk set his sights on making chips and yet other firms have mastered the process to an art?

Expanding renewables is increasingly viewed as Europe’s clearest path to reviving its industrial standing, as persistently high energy costs eat into the region’s manufacturing base. Electricity across the EU is still priced at more than twice pre-Ukraine war levels, and the structural exposure that sent prices there has not eased.

China is moving to strengthen the digital foundations of its economy, with a new policy calling for a nationwide blockchain system and a coordinated computing network as part of a broader industrial development strategy.

Chicago is preparing to make its commuter rail services cleaner with the introduction of battery-electric trains. Metra, the regional railroad serving the city and surrounding areas, has ordered eight new trainsets from Swiss manufacturer Stadler. The first trains are expected to begin carrying passengers by 2028.

Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports vehicles, electric carts and boats, announced the introduction of its 2027 Buck 570 utility task vehicle (UTV), developed and manufactured exclusively for a major national farm-and-ranch retailer. Built on Massimo’s established 500 Series platform, the new model features a retailer-exclusive camouflage design, half doors, a windshield and durable steel wheels, targeting the UTV market segment priced below $9,000. The company has received initial purchase orders, with shipments scheduled to begin during the week of Oct. 19, 2026. The Buck 570 will be available exclusively through the retail partner and is part of Massimo’s broader 2027 product introduction program, supporting its strategy to expand relationships with major national retailers through customized product offerings.

The global silver market is expected to record another supply deficit this year, as demand continues to outpace available supply. According to the World Silver Survey, this metal’s market could face a shortfall of more than 46 million ounces, quite an increase from the 40.3 million ounces recorded last year.

Bangladesh is currently grappling with a major measles outbreak that has seen more than 200,000 suspected cases of the disease recorded in the country, so far. Of those suspected cases, 22,000 have been confirmed by laboratory tests. These statistics cover mid-March to early October, according to the World Health Organization.

Close to 1,000 workers at a Kansas City-area assembly plant have been sent home without a return date, caught in the fallout from Washington’s withdrawal of federal EV purchase support . General Motors had been targeting around 150,000 Chevrolet Bolts at the facility before early next year.

The federal government has awarded $1.5 million to two healthcare research organizations pursuing projects aimed at improving the use and exchange of health information.

Knightscope (NASDAQ: KSCP), a security technology company developing autonomous security solutions, announced preliminary, unaudited third-quarter 2026 revenue of approximately $8.7 million, up 177% from $3.1 million in the prior-year period, marking its third consecutive quarter of triple-digit year-over-year revenue growth. Revenue for the first nine months of 2026 reached approximately $23.7 million, a 170% increase from $8.8 million a year earlier. The company also reported approximately $27 million in renewals, bookings and client awards and highlighted the launch of its Autonomous Security Force at GSX 2026. The preliminary revenue figures remain subject to completion of quarter-end financial closing procedures.

Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, announced the completion of a 1-for-150 reverse stock split effective Oct. 20, 2026, reducing its outstanding common shares from approximately 543.9 million to 3.6 million. The company’s shares began trading on a split-adjusted basis under the temporary symbol NGTFD on Oct. 20 and will revert to NGTF after 20 trading days. The reverse split applies proportionately to all shareholders, with fractional shares rounded up to the next whole share, and does not change the number of authorized shares.

Artificial intelligence is creating opportunities that extend well beyond the software powering it. As demand for computing infrastructure grows, semiconductor manufacturers face increasingly sophisticated production requirements, while businesses across other industries continue exploring automation to improve operational efficiency. For companies seeking to participate in these developments, the challenge is not simply identifying promising technologies, but building the capabilities and commercial relationships needed to bring them to market.

NanoViricides, Inc. (NYSE American: NNVC) announced positive results from a juvenile mouse study evaluating the safety, tolerability and toxicity of its broad-spectrum antiviral drug NV-387, supporting its potential advancement into pediatric clinical trials. The 12-day repeated-dose study found NV-387 Oral Gummies were well tolerated at all tested dose levels, with no mortality, systemic toxicity or treatment-related adverse effects. The highest tested dose of 3,690 mg/kg/day was established as the “No Observed Adverse Effect Level” (NOAEL), with no maximum tolerated dose identified. The company believes the findings could support pediatric enrollment in future clinical trials for Ebola, Mpox and measles, subject to further clinical development and regulatory requirements.

TruGolf (NASDAQ: TRUG) was featured in an AINewsWire editorial examining the growing institutional adoption of blockchain technology and the importance of regulatory compliance in tokenized asset markets. The editorial highlights TruGolf’s acquisition of Polymath Research Inc. and its Polymesh Layer-1 blockchain, which provides infrastructure for regulated digital securities. Polymath reported more than $132 million in tokenized assets issued on its platform by year-end 2025, with more than 65 active issuers and over 50 ecosystem partners. The editorial also discusses plans to deploy the technology within TruGolf Links Franchising through tokenized equipment leasing and fractional ownership opportunities, along with Polymath’s exploration of a tokenized film investment platform with CineCity Studios.

Olenox Industries (NASDAQ: OLOX) announced the completion of its $21.7 million acquisition of Wildboy Holdings, Ltd. and IPD Industries, Inc., combining natural gas resources and processing infrastructure in British Columbia with a power-development platform in West Texas. The acquisitions support the company’s strategy to develop an integrated gas-to-power-to-compute platform serving artificial intelligence, data centers and digital-asset operations. The transaction was financed almost entirely through Series F preferred stock, convertible into common shares subject to certain restrictions. The Wildboy assets include approximately 184,785 acres, a natural gas processing facility with capacity of up to 144 million cubic feet per day and approximately 56.8 billion cubic feet of proved developed natural gas reserves.

This article has been disseminated on behalf of ESGold Corp. and may include paid advertising.

Rezolve Ai (NASDAQ: RZLV), a provider of AI-powered commerce and payments solutions, announced a commercial agreement with Revolut through its Reward business, creating a new distribution channel for participating retail partners to reach eligible customers within Revolut’s financial app. The agreement supports Rezolve Ai’s strategy of expanding merchant participation, customer engagement and transaction-linked rewards across agreed markets. Through Rezolve Reward, merchants can offer funded incentives tied to qualifying purchases, connecting retailer investment directly to consumer activity. Specific campaigns, participating merchants, markets, incentive rates and launch dates will be determined separately. The companies will discuss the opportunity at Money20/20 in Las Vegas on Oct. 20, 2026.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

Streamex (NASDAQ: STEX), a technology company focused on commodity tokenization, announced that the seventh monthly yield distribution for its gold-backed, yield-bearing GLDY token was scheduled for Oct. 19, 2026, covering Sept. 1-30. The distribution totals 10.286094 GLDY tokens, equivalent to 10.286094 ounces of gold, with holders receiving 0.003070 ounces of GLDY per token. GLDY currently earns an annualized yield of 3.735%, generated through the company’s institutional gold leasing program, against a targeted annualized yield of 3.5%. Yield payments are distributed monthly in additional GLDY tokens.

ECGI Holdings (OTC: ECGI) announced its placement in an AINewsWire editorial titled “The Future of Healthcare: AI-Powered, Coordinated and Proactive Care,” highlighting the shift in U.S. healthcare toward preventive, coordinated care. The editorial examines rising healthcare expenditures, the expansion of Medicare Advantage and the growing financial incentives for health plans to improve patient outcomes. It also highlights ECGI’s completed acquisition of Avanta Group, a developing platform encompassing a Medicare Advantage health plan, management services and AI-enabled health technology. The acquisition positions ECGI to participate in the growing market for coordinated, proactive healthcare solutions.

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, is expanding its use of human-relevant testing methods across its oncology research programs, seeking to generate more clinically informative preclinical data while reducing the number of animals required for drug development.

Oncotelic Therapeutics (OTCQB: OTLC) announced that Chief Business Officer Saran Saund will deliver the opening keynote on the second day of the 22nd Drug Discovery Strategic Summit on Oct. 22, 2026, at 9 a.m. Pacific Time in Millbrae, California. The presentation will explore partition and aggregation as an organizing principle for AI-enabled drug discovery, emphasizing how complex research questions can be divided into focused investigations and findings combined to develop testable hypotheses. Saund will discuss the company’s proprietary PDAOAI platform, which indexes approximately 29 million PubMed abstracts, along with its international intellectual property strategy, planned expansion into genetic discovery and Fastbot/Membot technology designed to make AI-powered research accessible to individual investigators.

AINewsWire Editorial Coverage : Experimentation is giving way to commitment as Wall Street’s biggest firms embrace blockchain. BlackRock CEO Larry Fink expects “every stock, every bond” to eventually settle on a shared, tokenized ledger and Forbes reports that institutions are moving toward a tokenized market that could reach $13 trillion. On-chain movement has already begun for Treasuries and securities. Real-economy assets, such as equipment, franchises, real estate and private credit, represent the wave coming next. Compliance is where progress stalls. Any asset carrying securities obligations needs identity verification, transfer restrictions and regulatory controls written directly into the ledger. TruGolf Holdings Inc . (NASDAQ: TRUG) ( profile ) now holds that layer, having acquired Polymath Research Inc. along with its Layer-1 blockchain, Polymesh. Less than a week after the acquisition closed, TruGolf’s franchise subsidiary, TruGolf Links Franchising, signed an intercompany agreement with Polymath to provide professional services and move the TruGolf Links capitalization table onto Polymath’s regulated digital securities infrastructure. In addition, earlier this month, Polymath disclosed that it is exploring a tokenized film investment platform alongside CineCity Studios, extending TruGolf’s reach from golf into entertainment finance. Having closed the acquisition, TruGolf now has a foothold in the regulated tokenization and digital securities infrastructure market while still staying rooted in the golf space, working alongside established players in both sectors, including Robinhood Markets Inc. (NASDAQ: HOOD), Circle Internet Group Inc. (NYSE: CRCL), Acushnet Holdings Corp. (NYSE: GOLF) and…

Stocktwits, the leading social platform for investors and traders, wrapped Stocktoberfest presented by Tradr ETFs, its flagship annual event, held in New York City from October 5 to 7. This year’s event brought together more than 350 ticketed guests, including 40 financial creators with a combined audience of more than 11 million followers, for three days of networking, entertainment, and conversations with the public company executives shaping today’s markets.

Greenland Mines (NASDAQ: GRML; FSE: HK6), a Greenland-focused critical-minerals developer, announced that its common stock has begun trading on Xetra, the electronic trading platform operated by Deutsche Börse AG in Germany. MWB Fairtrade AG will serve as designated sponsor, supporting trading liquidity and turnover. The addition of Xetra is intended to broaden the company’s investor base, improve liquidity and enhance price discovery by providing greater access to European institutional and retail investors.

Quantum BioPharma (NASDAQ: QNTM) was featured in a Men’s Fitness article by Lakshan Weeraratne examining clinical trial results for Unbuzzd, an alcohol recovery formulation developed by Quantum and licensed to Unbuzzd Wellness. The article highlights findings from a company-sponsored, placebo-controlled study involving 26 healthy adults, with 24 completing both treatment sessions. Researchers reported significantly lower estimated blood alcohol concentrations at several time points, improved self-rated alertness and reduced headache severity on certain assessments. Among 17 participants identified as rapid responders, the average percentage decline in estimated blood alcohol during the first 30 minutes was 40.7% greater with Unbuzzd than with placebo.

The International Monetary Fund has warned that a sudden fall in the value of artificial intelligence shares could become a serious problem for the whole world economy. The concern is not simply that technology companies may lose money. It is that so many investors, banks, funds, and businesses are now connected to AI stocks that a sharp drop in their prices could spread quickly through global financial markets.

A new therapeutic vaccine has shown early promise in extending the lives of patients with aggressive brain tumors, with two-thirds of participants in a small German study still alive eight years on from their enrollment. Results from the long-term follow-up, published in the journal Nature, also showed that 42% of participants had seen no recurrence during that period, a figure that surprised even the researchers involved.

Gold prices regained some ground in early trading on Friday, recording a 1% uptick during the Asian trading session. This bounce comes after a major sell-off that followed the release of inflation data showing that average prices of commodities were still ticking up and the Fed could most likely tighten monetary policy further when it meets in about two weeks.

Frontieras North America announced a multi-year global partnership with the Cadillac Formula 1(R) Team, naming Frontieras as the team’s Official Energy Transformation Partner. The collaboration brings together two American companies focused on advancing innovation in energy and motorsports, with a shared commitment to challenging established industry practices. The Cadillac Formula 1(R) Team, formed by TWG Motorsports and General Motors (NYSE: GM), is the first new team to enter the Formula 1(R) grid in a decade.

Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics , is advancing a multifaceted growth strategy that brings together artificial intelligence, robotics and advanced manufacturing. In an October 8 shareholder update , the company highlighted progress across its principal business initiatives, underscoring its efforts to translate recent strategic developments into commercial opportunities.

ECGI Holdings (OTC: ECGI) is featured in an AINewsWire editorial examining the shift toward preventive, coordinated healthcare and the growing role of artificial intelligence in improving patient outcomes and managing costs. The editorial highlights ECGI’s acquisition of Avanta Group, a developing integrated healthcare platform encompassing Medicare Advantage insurance, management services, AI-enabled technology, consumer health and healthcare infrastructure. The acquisition positions ECGI to pursue opportunities in a U.S. healthcare market that reached $5.3 trillion in 2024, with Medicare Advantage payments projected to total $574 billion in 2026. The editorial also discusses the potential for integrated technology and care coordination to improve efficiency, patient engagement and access to services.

Knightscope (NASDAQ: KSCP), a security technology company developing autonomous security solutions, announced the initial deployment of Signals, its proprietary orchestration software and real-time digital twin platform, at its Silicon Valley headquarters. Signals creates a continuously updated, three-dimensional model of a facility by integrating data from cameras, sensors and autonomous security machines, enabling remote monitoring and virtual patrols from a single interface. The initial deployment incorporates the company’s K7 Autonomous Security Robot, K1 Capsule and K1 Super Towers, with plans to integrate live data from human security agents and additional robotic systems. Knightscope will host a public demonstration of Signals on Nov. 5, 2026, at 4 p.m. ET.

TransCode Therapeutics (NASDAQ: RNAZ), a clinical-stage company developing immuno-oncology and RNA-based therapeutics for high-risk and advanced cancers, announced that a poster featuring its lead therapeutic candidate, TTX-MC138, will be presented at the European Society for Medical Oncology (“ESMO”) Congress 2026 on Oct. 23 in Madrid, Spain. The presentation will highlight the latest clinical update from the Phase 1a trial evaluating TTX-MC138 in patients with advanced solid tumors. TTX-MC138 is an investigational therapeutic designed to target miR-10b, a microRNA associated with metastatic disease progression.

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated, commercial-stage biopharmaceutical company, announced that a poster examining the effects of TONMYA(R) (cyclobenzaprine HCl sublingual tablets) on fibromyalgia symptoms and physical function will be presented at the International Association for the Study of Pain (“IASP”) 2026 World Congress on Pain, scheduled for Oct. 26-30, 2026, in Bangkok, Thailand. TONMYA received U.S. Food and Drug Administration approval on Aug. 15, 2025, and was commercially launched in the United States on Nov. 17, 2025.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

Disseminated on behalf of LaFleur Minerals Inc. and may include paid advertising.

AINewsWire Editorial Coverage : American healthcare is moving from treating illness after it strikes to preventing it before it starts. U.S. health spending reached $5.3 trillion in 2024, and Medicare Advantage now covers 35.2 million people, or 55% of eligible beneficiaries. KFF projects Medicare Advantage payments of $574 billion in 2026, giving health plans a powerful reason to keep members healthy. That shift is opening the door for a new kind of player. ECGI Holdings Inc . (OTC: ECGI) ( profile ) has completed its acquisition of Avanta Group, a developing platform that spans a Medicare Advantage health plan, management services and AI-enabled health technology. The acquisition gives ECGI a direct path into coordinated, proactive care just as the industry is searching for better ways to deliver it. ECGI is working alongside others operating in the U.S. managed healthcare ecosystem, including industry leaders such as United Health Group Inc. (NYSE: UNH), CVS Health Corporation (NYSE: CVS), Elevance Health Inc. (NYSE: ELV) and…

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements.

Recent SEC Form 4 filings disclosed open-market purchases of Nano-X Imaging Ltd.’s (NASDAQ: NNOX) (“Nanox”) ordinary shares by CEO Erez Meltzer and Board Director Dan Suesskind, adding to purchases reported in recent months by Meltzer, Suesskind and Board Director Nogah Keinan. The transactions reflect share purchases made directly in the open market by the company’s senior leadership and board members, with additional details available in the respective SEC filings. This comes as Nanox continues to advance its integrated medical imaging and healthcare services platform, which combines proprietary digital X-ray technology, AI-powered imaging analytics, cloud-based software, remote radiology services and healthcare IT solutions to support earlier disease detection, improve clinical workflows and expand access to preventive care.

Disseminated on behalf of Redwood AI Corp. and may include paid advertising.

Silynxcom (NYSE American: SYNX) has received two consecutive purchase orders totaling approximately $400,000 from a leading global defense company for its CLARUS In-Ear Headset product family, with the systems designated for a European army. The modular CLARUS platform combines hearing protection, tactical communications, an in-ear microphone and situational awareness features, including drone detection. According to CEO Nir Klein, the orders reflect the company’s established relationship with a major defense customer and continued recognition of its products among European military organizations. The purchases also support Silynxcom’s efforts to expand its presence in European defense markets as military and security customers seek reliable communications equipment designed to enhance operational effectiveness and soldier safety.

Nanox (NASDAQ: NNOX) announced that its subsidiary, Nanox AI Ltd., has entered into a distribution agreement with Technologic s.r.l., an Italian company affiliated with Tecnologie Avanzate, to commercialize its AI-powered bone health solution, HealthOST, in Italy. The agreement is intended to expand Nanox AI commercial presence in the Italian market, leveraging Technologic experience and local market knowledge. HealthOST analyzes eligible routine CT scans to provide qualitative and quantitative assessments of the spine, helping clinicians identify patients who may benefit from further evaluation for musculoskeletal conditions such as osteoporosis.

Wrap Technologies (NASDAQ: WRAP) has developed a new operational doctrine designed to help law enforcement officers manage encounters when verbal de-escalation alone does not resolve a situation. The framework combines communication, recognition of resistance, tactical positioning, time and distance, and remote restraint using the company’s BolaWrap 150 device, which deploys a tether intended to restrain a person without electrical incapacitation or chemical irritants. The approach is designed to give officers an additional option in certain encounters, including behavioral and mental health emergencies, while emphasizing the use of the lowest reasonable level of response and continuous reassessment as circumstances change. Following an ATF ruling classifying the BolaWrap 150 as an instrument of restraint rather than a firearm or other weapon under federal law, Wrap has submitted its training curriculum for independent validation ahead of a potential application for California POST certification. If certification is obtained, the company plans to distribute standardized training through its WRAP Tactics digital learning platform, potentially supporting wider agency adoption and recurring training-related revenue.

Nanox (NASDAQ: NNOX), a medical imaging technology company, announced that its Nanox.ARC X digital tomosynthesis system has been named one of TIME’s Best Inventions of 2026. The U.S. Food and Drug Administration-cleared system captures X-ray images from multiple angles, generating up to 200 coronal images per scan to produce three-dimensional views of the body at up to 80% less radiation than computed tomography (“CT”) for equivalent body parts. Designed with a smaller footprint than conventional CT systems, Nanox.ARC X operates using a standard 110-volt power outlet and features simplified installation, operator workflows and remote upgrade capabilities. The company plans to showcase the system at the RSNA 2026 Annual Meeting in Chicago. Nanox previously received a special mention on TIME’s Best Inventions of 2024 list for its artificial intelligence imaging solutions.

American Fusion(TM) (OTCBQ: AMFN), a developer of next-generation fusion energy technologies, is restructuring up to $2.88 million in stock-based compensation obligations into long-term preferred equity as it works to organize its capital structure ahead of a planned national securities exchange listing and potential institutional financing.

DarioHealth (NASDAQ: DRIO) announced results of a review conducted by the Managed Care Services Team of Aon plc evaluating the clinical and financial impact of its AI-powered chronic condition management services. Based on data and studies provided or identified by DarioHealth, Aon concluded that the evidence supports estimated annual healthcare cost reductions of 2.5% to 7.2% across a covered population, equivalent to approximately $3.8 million to $10.8 million annually for a representative population of 20,000 covered lives. Aon also estimated that management of multiple conditions and access to physicians, which were excluded from the initial calculations, could contribute an additional 1.6 to 2.8 percentage points in savings.